SCHEMBL23918093

SCHEMBL23918093

c1ccc(N(c2ccccc2)c2ccc3c(c2)Sc2ccc(N(c4ccccc4)c4ccc5sc6ccccc6c5c4)cc2S3)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.41
CYP1A2 P05177 2/20 0.37
MAPT P10636 6/20 0.36
ALDH1A1 P00352 5/20 0.36
RAB9A P51151 3/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PTPN7 P35236 1/20 0.35
DUSP3 P51452 1/20 0.35
PTPN12 Q05209 1/20 0.35
PTPN22 Q9Y2R2 1/20 0.35
PTGIR P43119 1/20 0.34
TDP1 Q9NUW8 4/20 0.33
L3MBTL1 Q9Y468 4/20 0.33
KDM4E B2RXH2 3/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22180418 0.92 KDM4E (0.43) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL23918094 0.91 ALDH1A1 (0.42) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL23918117 0.91 ALDH1A1 (0.42) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL22180295 0.90 GPR3 (0.33) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL18928088 0.89 GPR3 (0.52) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL12936133 0.89 GPR3 (0.52) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL23314347 0.89 GPR3 (0.52) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL15730671 0.89 GPR3 (0.52) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL12936134 0.89 GPR3 (0.52) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL26154378 0.89 GPR3 (0.52) GPR3CYP1A2MAPTALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320258-A1 COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320258-A1 COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, OR10J3, OCIAD1 GPR3 4727/4885CYP1A2 1389/4885MAPT 3115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.